The role of germline mutations in the breast-ovarian cancer predisposition genes BRCA1 and BRCA2 in the risk of familial melanoma development is still a matter of debate [54] and the exact melanoma risk increase (if any) in mutation carriers is uncertain. This evidence concerns the gene BRCA1 and melanoma.